94 related articles for article (PubMed ID: 21816012)
1. Polymyositis associated with hepatitis B: management with entacavir and prednisolone.
Wong MH; Sockalingam S; Zain A
Int J Rheum Dis; 2011 Aug; 14(3):e38-41. PubMed ID: 21816012
[TBL] [Abstract][Full Text] [Related]
2. [A case of polymyositis associated with chronic active hepatitis].
Fujitake J; Saida K; Nishitani H; Suginoshita T; Osaki S
Rinsho Shinkeigaku; 1990 Jan; 30(1):55-61. PubMed ID: 2184964
[TBL] [Abstract][Full Text] [Related]
3. Quantitative hepatitis B surface antigen levels in patients with chronic hepatitis B after 2 years of entecavir treatment.
Fung J; Lai CL; Young J; Wong DK; Yuen J; Seto WK; Yuen MF
Am J Gastroenterol; 2011 Oct; 106(10):1766-73. PubMed ID: 21826112
[TBL] [Abstract][Full Text] [Related]
4. [A case of fasciitis associated with Basedow's disease and polymyositis].
Mihori A; Morio T; Nakayama M; Ono S; Shimizu N
Rinsho Shinkeigaku; 1998 Jan; 38(1):27-31. PubMed ID: 9597906
[TBL] [Abstract][Full Text] [Related]
5. Entecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis B.
Lai CL; Shouval D; Lok AS; Chang TT; Cheinquer H; Goodman Z; DeHertogh D; Wilber R; Zink RC; Cross A; Colonno R; Fernandes L;
N Engl J Med; 2006 Mar; 354(10):1011-20. PubMed ID: 16525138
[TBL] [Abstract][Full Text] [Related]
6. Effect of long-term lamivudine in chronic hepatitis B virus-infected children.
Ozgenç F; Arikan C; Sertoz RY; Nart D; Aydogdu S; Yagci RV
Antivir Ther; 2004 Oct; 9(5):729-32. PubMed ID: 15535410
[TBL] [Abstract][Full Text] [Related]
7. Loss of HBsAg antigen during treatment with entecavir or lamivudine in nucleoside-naïve HBeAg-positive patients with chronic hepatitis B.
Gish RG; Chang TT; Lai CL; de Man R; Gadano A; Poordad F; Yang J; Brett-Smith H; Tamez R
J Viral Hepat; 2010 Jan; 17(1):16-22. PubMed ID: 19622117
[TBL] [Abstract][Full Text] [Related]
8. [Antiviral effects of entecavir in patients with hepatitis B virus-related cirrhosis].
Xu Y; Wang JB; Xu J; Jiao J; Zhang YG; Ji SW; Zhao P; Guo HH; Li Y; Zhou CY
Zhonghua Gan Zang Bing Za Zhi; 2010 Feb; 18(2):109-12. PubMed ID: 20196949
[TBL] [Abstract][Full Text] [Related]
9. Successful entecavir plus prednisolone treatment for hepatitis B virus-associated membranoproliferative glomerulonephritis: A case report.
Kataoka H; Mochizuki T; Akihisa T; Kawasoe K; Kawachi K; Makabe S; Sawada A; Manabe S; Sato M; Amemiya N; Mitobe M; Akanuma T; Ito Y; Inoue T; Suzuki T; Matsui K; Moriyama T; Horita S; Ohara M; Honda K; Nitta K
Medicine (Baltimore); 2019 Jan; 98(2):e14014. PubMed ID: 30633192
[TBL] [Abstract][Full Text] [Related]
10. Three years of continuous entecavir therapy in treatment-naïve chronic hepatitis B patients: VIRAL suppression, viral resistance, and clinical safety.
Yuen MF; Seto WK; Fung J; Wong DK; Yuen JC; Lai CL
Am J Gastroenterol; 2011 Jul; 106(7):1264-71. PubMed ID: 21364549
[TBL] [Abstract][Full Text] [Related]
11. A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B.
Chang TT; Gish RG; de Man R; Gadano A; Sollano J; Chao YC; Lok AS; Han KH; Goodman Z; Zhu J; Cross A; DeHertogh D; Wilber R; Colonno R; Apelian D;
N Engl J Med; 2006 Mar; 354(10):1001-10. PubMed ID: 16525137
[TBL] [Abstract][Full Text] [Related]
12. [A case of polymyositis presenting pregnancy with acute respiratory failure].
Ishikawa S; Takei Y; Maruyama T; Koyama S; Hanyu N
Rinsho Shinkeigaku; 2000 Feb; 40(2):140-4. PubMed ID: 10835934
[TBL] [Abstract][Full Text] [Related]
13. [Clinical efficacy of entecavir therapy and factors associated with treatment response in naive chronic hepatitis B patients].
Lee MH; Lim SG; Jeon SJ; Kang CJ; Cho YJ; Kim SS; Lee D; Cheong JY; Cho SW
Korean J Hepatol; 2009 Dec; 15(4):446-53. PubMed ID: 20037263
[TBL] [Abstract][Full Text] [Related]
14. [Five years trial of entecavir for chronic hepatitis B patients failed with lamivudine therapy in the Chongqing area].
LI H; WANG ZY; ZHANG DZ; SHI XF; ZHOU Z; REN H
Zhonghua Gan Zang Bing Za Zhi; 2009 May; 17(5):338-41. PubMed ID: 19497197
[TBL] [Abstract][Full Text] [Related]
15. [Efficacy and predictors of the virologic response to entecavir therapy in nucleoside-naive patients with chronic hepatitis B].
Myung HJ; Jeong SH; Kim JW; Kim HS; Jang JH; Lee DH; Kim N; Hwang JH; Park YS; Lee SH
Korean J Hepatol; 2010 Mar; 16(1):57-65. PubMed ID: 20375643
[TBL] [Abstract][Full Text] [Related]
16. Treatment of chronic hepatitis B virus infection - Dutch national guidelines.
Buster EH; van Erpecum KJ; Schalm SW; Zaaijer HL; Brouwer JT; Gelderblom HC; de Knegt RJ; Minke Bakker C; Reesink HW; Janssen HL;
Neth J Med; 2008; 66(7):292-306. PubMed ID: 18663260
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of entecavir in lamivudine-refractory patients with chronic hepatitis B: randomized controlled trial in Japanese patients.
Suzuki F; Toyoda J; Katano Y; Sata M; Moriyama M; Imazeki F; Kage M; Seriu T; Omata M; Kumada H
J Gastroenterol Hepatol; 2008 Sep; 23(9):1320-6. PubMed ID: 18554238
[TBL] [Abstract][Full Text] [Related]
18. Polymyositis: rare complication of hepatitis B vaccination. An unusual cause of toxic shock syndrome.
Ramírez-Rivera J; Vega-Cruz AM; Jaume-Anselmi F
Bol Asoc Med P R; 2003; 95(6):13-6. PubMed ID: 15449786
[TBL] [Abstract][Full Text] [Related]
19. A case of polymyositis with dilated cardiomyopathy associated with interferon alpha treatment for hepatitis B.
Lee SW; Kim KC; Oh DH; Jung SS; Yoo DH; Kim SY; Choe G; Kim TH
J Korean Med Sci; 2002 Feb; 17(1):141-3. PubMed ID: 11850606
[TBL] [Abstract][Full Text] [Related]
20. [Severe exacerbation of chronic hepatitis B during therapy with corticosteroids and lamivudine therapy and successful short-term combination therapy with interferon-beta and interferon-gamma].
Musch E; Malek M; Chrissafidou A
Z Gastroenterol; 2003 May; 41(5):425-8. PubMed ID: 12772056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
